Multi-layered tissue engineered skin composed of hair follicle cells, its preparation and use
A method for producing multilayered tissue engineered skin using autologous hair follicle cells addresses the challenges of exogenous component dependence and cell aging by forming a layered structure similar to physiological skin, enhancing treatment efficacy and reducing costs.
Patent Information
- Application Number
- JP2023577401
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-12-02
- Filing Date
- 2023-07-27
- Publication Date
- 2024-12-11
- Estimated Expiration
- 2043-07-27
AI Technical Summary
Existing tissue-engineered skin products face challenges in developing a skin mixed cell culture system free of exogenous components and maintaining keratinized features during in vitro culture, leading to brittleness and difficulty in forming structural features similar to physiological epidermis, with differentiated cells aging and failing to survive without sufficient stem cells.
A method for producing multilayered tissue engineered skin using autologous hair follicle cells, involving enzymatic digestion, expansion culture, and maturation differentiation to form a layered structure of basal, spinous, and granular layers, using specific culture solutions to induce differentiation into mature epidermal cells without exogenous components.
The method results in a tissue-engineered skin composed of autologous cells with tight intercellular connections and good toughness, suitable for treating conditions like vitiligo by promoting repigmentation and reducing immune rejection, with reduced material-related limitations and industrial costs.
Smart Images

Figure 2024545740000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to the field of biological technology, in particular to multi-layered tissue engineered skin consisting of hair follicle cells, its preparation method and use. [Background technology]
[0002] Skin is one of the largest organs of the human body, covering the entire body surface and accounting for approximately 16% of body weight. Skin has important functions such as secretion, absorption, body protection, sensation and immunity. Physiological skin is divided into the epidermis, dermis and subcutaneous tissue. Trauma, burns, inflammation and ulcers often cause loss of all layers of the skin. Autoimmune diseases such as vitiligo can also cause loss of melanocytes in the epidermis, resulting in abnormal skin color. Tissue-engineered skin is the earliest and fastest-growing tissue-engineered product among all tissue-engineered organs, and is the most technologically mature tissue-engineered product. Numerous experimental and clinical studies have proven that tissue-engineered skin can be used as a substitute for skin wound repair and reconstruction, and mature tissue-engineered skin products have been launched both at home and abroad. In the field of vitiligo subdivision, tissue-engineered epidermis products have not yet appeared, mainly due to the difficulty of developing a skin mixed cell culture system without exogenous components. In addition, in the traditional in vitro culture process, epidermal cells tend to lose their keratinization characteristics, which increases the brittleness of the skin fragments of the tissue-engineered epidermis produced, making it difficult to form structural characteristics similar to physiological epidermis, and affecting its function.
[0003] In tissue-engineered skin, cell activity is particularly important. If most of the cells are already differentiated, there are few stem cells, and the repair wound is large, the differentiated cells will gradually age and fall off, and if there are not enough stem cells to replenish them or cells that have migrated to the surrounding area, the graft will not survive. Therefore, sufficient stem cells are very important for tissue-engineered skin and are the key to ensuring cell renewal and long-term survival of the graft in the wound. Hair follicle epithelial cells are structurally continuous with keratinocytes in the epidermis layer, have similar cell morphology, and can transform into each other under certain conditions. Hair follicle epithelial cells are mainly composed of outer root sheath cells of hair matrix cells. By analyzing the clonal formation ability of hair follicle cells in different parts, we found cells with high proliferation ability in the hair follicle bulge region, proving the existence of stem cells in the hair follicle bulge region. In recent years, the hair follicle bulge region has been recognized as a reservoir of stem cells. It not only participates in the formation of hair follicles and maintains the cyclic growth of hair, but also participates in the development of the epidermis, forming temporary amplifying cells in the basal layer of the epidermis, maintaining the self-renewal of the epidermis, and may be responsible for the important role of repairing the epidermis during the process of skin injury. Melanocyte stem cells have also been found in the hair follicle bulge region. Therefore, hair follicles are a better source of seed cells for tissue engineering skin. Research has found that skin flakes derived from hair follicle outer root sheath cells have stronger adhesive properties, form an "edge effect", and the skin flake cells release large amounts of growth factors and cytokines to stimulate the migration of epithelial cells, promote wound contraction, and wound reduction. Such phenomena have not been reported in general skin epidermal grafts and conventional monolayer cultured keratinocyte grafts.
[0004] The existing cell culture system for tissue engineered skin products using hair follicle epithelial cells as seed cell source and containing live cells is highly dependent on serum and fibroblast trophoblasts. Due to the use of culture reagents, culture conditions, serum, types of exogenous factors added, cell culture density, etc., there are differences in cell heterogeneity, differentiation ability, proliferation ability, and cell functions after expansion culture, which limits the standardized production and medical use of skin fragments. Summary of the Invention [Problem to be solved by the invention]
[0005] The object of the present invention is to provide a multi-layered tissue engineered skin consisting of hair follicle cells, its preparation method and use, in order to overcome the above-mentioned deficiencies existing in the prior art.
[0006] The multi-layered tissue engineered skin according to the present invention is composed only of autologous hair follicle cells, and forms a layered structure of basal layer, spinous layer, and granular layer, which are rich in melanocytes, like physiological skin. [Means for solving the problem]
[0007] The object of the present invention can be achieved by the following technical solutions.
[0008] The present invention relates to a method for producing a multi-layered tissue engineered skin composed of hair follicle cells, comprising the steps of: The method includes the steps of digesting autologous hair follicles in vitro, expanding and culturing the mixed hair follicle cells, and maturing and differentiating the mixed hair follicle cells and forming a tissue structure, In the step of digesting the in vitro autologous hair follicles, The hair follicle tissue is digested by a two-step enzyme digestion method, and the hair follicle bulge region, which mainly contains hair follicle stem cells and melanocytes, the outer root sheath, which is rich in keratinocytes, and the hair follicle region, which is rich in dermal papilla cells, are effectively digested to obtain hair follicle mixed cells; In the step of expanding the hair follicle mixed cells, The hair follicle single cell suspension containing the mixed hair follicle cells was expanded in two stages using culture medium A and culture medium B to obtain the mixed hair follicle cells after expansion culture. In the step of maturing and differentiating the hair follicle mixed cells and forming a tissue structure, After the expansion culture of the hair follicle mixed cells in culture medium B, the cells are cultured until the confluence rate reaches 80%, and then cultured in culture medium C. The culture medium is changed every day during the culture in culture medium C, and the hair follicle mixed cells, which are rich in hair follicle stem cells, pre-melanocytes, and keratinocytes, are induced to differentiate into mature epidermal cells in culture medium C. The matured cells are arranged in layers, and the epidermal cells are tightly bound together by the action of culture medium C, forming a multi-layered tissue engineered skin composed of hair follicle cells. The culture solution A is When the volume is 500 ml, the components are 500 ml of commercially available keratinocyte medium with clearly defined components, insulin-like growth factor 1-10 ng / ml, keratinocyte growth factor 0.5-5 ng / ml, endothelin 100-500 ng / ml, melanocyte-stimulating hormone α 20-80 ng / ml, and gentamicin 20-100 μg / ml. The culture medium B is When the volume is 500 ml, the components are 500 ml of a commercially available keratinocyte medium with clearly defined components, insulin-like growth factor 1-10 ng / ml, basic fibroblast growth factor 1-10 ng / ml, epidermal growth factor 10-50 ng / ml, adrenocorticotropic hormone 10-50 ng / ml, and melanocyte-stimulating hormone α 20-80 ng / ml. The culture solution C is The present invention provides a production method in which, when the volume is 500 ml, the components are 370 ml of commercially available DMEM medium, 125 ml of commercially available F12 medium, 5 ml of non-essential amino acids, 1 to 10 ng / ml of insulin-like growth factor, 1 to 10 μg / ml of taurine, 1 to 5 μg / ml of 5-hydroxytryptamine hydrochloride, 20 to 80 μg / ml of insulin, 10 to 50 μg / ml of recombinant transferrin, 1 to 10 ng / ml of basic fibroblast growth factor, 1 to 10 ng / ml of triiodothyronine, 0.5 to 5 μg / ml of hydrocortisone, 0.5 to 5 ng / ml of keratinocyte growth factor, 10 to 50 ng / ml of epidermal cell growth factor, 10 to 50 ng / ml of adrenocorticotropic hormone, and 10 to 50 μg / ml of adenosine.
[0009] In one embodiment of the present invention, ex vivo autologous hair follicles refer to hair follicles isolated from the human body, i.e. the method according to the present application is based on ex vivo tissue.
[0010] In one embodiment of the present invention, the method of obtaining extracorporeal autologous hair follicles may be a conventional technique, such as sucking out hair follicles with a hair follicle remover. A specific method of obtaining hair follicles may be a FUE (follicle unit extraction) hair follicle extraction method in hair transplantation, and more specifically, see Follicular Unit Extraction: Minimally invasive surgery for hair transplantation. Dermatol Surg. 2002; 28: 720-7. The tip of the hair follicle extracting device is pierced into the scalp skin under an electric press, the hair follicles are sucked out, and the hair follicles are lightly extracted with sterile elbow tweezers, and the structure of the hair follicles is completely maintained throughout the entire process.
[0011] In one embodiment of the present invention, a method for digesting hair follicular tissue by a two-step enzymatic digestion method includes a first enzymatic digestion and a second enzymatic digestion, In the first enzymatic digestion, the in vitro autologous hair follicle tissue was immersed in culture solution A containing 0.6 to 2.4 U / ml neutral protease and incubated overnight at 37°C. In the second enzymatic digestion, the hair follicle tissue is chopped the next day, TrypLE is added, and digested at 37°C for 10 to 40 minutes, followed by vigorously pipetting. After pipetting, the suspension containing the cells and tissue is filtered through a 100 μm sieve, the filtrate is centrifuged, and then a phosphate buffer solution is added to the cell mass. After washing 3 to 5 times, culture solution A is added to produce a single hair follicle cell suspension containing mixed hair follicle cells.
[0012] In one embodiment of the present invention, in a two-stage expansion culture method of a single hair follicle cell suspension containing mixed hair follicle cells using culture medium A and culture medium B, Mixed hair follicle cells were 4 ~10 6 The cells were inoculated at a cell concentration of 1 / ml onto a culture dish that had been covered with a substrate for 4 hours, culture medium A was added, and the cells were expanded under conditions of 5% CO2 and 37°C. The liquid was replaced every other day, and the cells were passaged when the confluence rate reached 80% or more. After passage, the cells were 4 ~10 6The cells are seeded at a cell concentration of / ml onto a culture dish coated with a substrate for 4 hours, culture medium B is added, and the cells are expanded under conditions of 5% CO2 and 37°C. The liquid is replaced every other day. Upon completing the simultaneous expansion culture of hair follicle stem cells, pre-melanocytes, and keratinocytes, mixed hair follicle cells after expansion are obtained.
[0013] In one embodiment of the present invention, the substrate for covering a culture dish contains, as its components, 500 ml of a commercially available phosphate buffer and 10 to 100 μg / ml of type IV collagen when the volume is adjusted to 500 ml.
[0014] In one embodiment of the present invention, in the maturation differentiation of hair follicle mixed cells and formation of a tissue structure, the hair follicle mixed cells after expansion culture are cultured for 10 4 ~10 5 pieces / cm 2 The cells are inoculated onto a substrate-coated culture dish at a density of 100 μg / cm2 and cultured in culture medium B at 5% CO2 and 37°C. When the confluence rate reaches 80%, the culture medium is changed to culture medium C, and the liquid is exchanged every other day.
[0015] The present invention further provides a multi-layered tissue engineered skin produced by the above-described method of production.
[0016] In one embodiment of the invention, the multi-layered tissue engineered skin comprises physiologically resembling melanoblasts and keratinocytes with stemness.
[0017] In one embodiment of the present invention, the multi-layered tissue engineered skin is a stratified tissue structure with physiological basal layer, spinous layer, and granular layer, and is rich in melanoblasts in the basal layer. The tissue engineered skin is rich in actively dividing basal layer-like cells with tight junctions between cells and good toughness.
[0018] The present invention further provides a use of the multi-layered tissue engineered skin produced by the above-mentioned production method, wherein the multi-layered tissue engineered skin is used for the production of biomedical materials. It is useful for the treatment of pigmentation defects and epidermal deficiency diseases.
[0019] In one embodiment of the present invention, the fabricated multi-layered tissue engineered skin, when used for stable vitiligo treatment, can promote repigmentation of vitiligo and achieve healing of vitiligo without immune rejection due to its autologous origin. Effect of the Invention
[0020] The method for producing multi-layered tissue engineered skin made of hair follicle cells according to the present invention includes digestion of autologous hair follicles in vitro, expansion and culture of mixed hair follicle cells, maturation and differentiation of mixed hair follicle cells, and formation of tissue structure. In the method for producing according to the present invention, there are no exogenous components in the culture system, and the tissue engineered epidermis produced is composed of only autologous cells, and due to the characteristics of the absence of allogeneic and xenogeneic trophoblast cells, the produced product is safer for clinical use. The cell composition is composed of mixed cells, mainly melanocytes and keratinocytes. Keratinocytes form a multi-layered structure, and a large amount of melanocytes are arranged on top of the basal layer similar to physiological epidermis. Due to the characteristics of these cells, this tissue engineered epidermis can expand the indications and be useful for surgical transplantation treatment of stable vitiligo, and can promote repigmentation of vitiligo.
[0021] The present invention adopts autologous hair follicles as the seed cell source for tissue engineered skin, which can greatly reduce the material-derived limitations and the donor's pain, and the autologous cells can avoid the immune rejection effect after transplantation, which is favorable for the integration of tissue engineered skin with the ground wound surface, and can achieve better therapeutic effects. The hair follicles used contain abundant stem cells, have active cell metabolism, high proliferation ability, and many passages, which is favorable for large-scale amplification of seed cells, and can reduce the amount of material harvested while at the same time reducing the industrialization costs.
[0022] The present invention provides a method for obtaining a multi-layered tissue structure epidermal skin similar to a physiological state, which is composed only of autologous hair follicle cells, forms a layered structure similar to the physiological basal layer, spinous layer, and granular layer, and contains abundant melanocytes in the basal layer, and is composed only of autologous hair follicle cells. The tissue engineered skin has a tight intercellular bond and good toughness, and is rich in actively dividing basal layer-like cells, which increases the success rate of transplantation, and the abundant melanocytes promote the re-pigmentation of the skin in the vitiligo area, thereby expanding the field of use of the tissue engineered skin. Since the autologous hair follicles are harvested, they are easy to obtain, painless to harvest, and reduce the cost of industrialization.
[0023] The research of the present invention has confirmed that it is biotechnologically feasible to construct a culture system of hair follicle-derived mixed cells with defined components and free of serum and nutrient layers, and that hair follicle-derived mixed cells can be used as seed cells for tissue-engineered epidermis to treat vitiligo. [Brief description of the drawings]
[0024] [Figure 1] This shows the cell morphology of mixed hair follicle cells in culture medium A in Example 1 (10x objective lens). [Diagram 2] This shows the cell morphology of mixed hair follicle cells in culture medium B in Example 1 (10x objective lens). [Diagram 3] 1 shows the cell morphology (10x objective lens) of mixed hair follicle cells in culture medium C in Example 1. [Figure 4] 1 shows the morphological structure of melanocytes in hair follicle mixed cells in Example 1 (10x objective lens). [Diagram 5] FIG. 2 is a multi-layered tissue-engineered skin (area: 21 cm2) made of hair follicle cells in Example 1. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0025] The invention will now be described in detail with reference to the drawings and specific embodiments.
[0026] In the following examples, experimental methods for which no specific conditions are specified generally follow standard conditions or those suggested by the manufacturer.
[0027] Example 1 Step 1: Prepare the culture medium Preparation of coated substrate: When the volume is 500 ml, the components are 500 ml of commercially available phosphate buffer, 30 μg / ml of type IV collagen, Preparation of culture medium A: When the volume is 500 ml, the components are 500 ml of a commercially available keratinocyte medium with clearly defined components, 10 ng / ml of insulin-like growth factor, 3 ng / ml of keratinocyte growth factor, 200 ng / ml of endothelin, 50 ng / ml of melanocyte-stimulating hormone α, and 50 μg / ml of gentamicin. Preparation of culture medium B: When the volume is 500 ml, the components are 500 ml of a commercially available keratinocyte medium with clearly defined components, 10 ng / ml of insulin-like growth factor, 4 ng / ml of basic fibroblast growth factor, 20 ng / ml of epidermal growth factor, 50 ng / ml of adrenocorticotropic hormone, and 50 ng / ml of melanocyte-stimulating hormone α. Preparation of culture medium C: When the volume is 500 ml, the components are 370 ml of commercially available DMEM medium, 125 ml of commercially available F12 medium, 5 ml of non-essential amino acids, 10 ng / ml of insulin-like growth factor, 5 μg / ml of taurine, 1 μg / ml of 5-hydroxytryptamine hydrochloride, 20 μg / ml of insulin, 20 μg / ml of recombinant transferrin, 4 ng / ml of basic fibroblast growth factor, 5 nM of triiodothyronine, 1.5 μg / ml of hydrocortisone, 3 ng / ml of keratinocyte growth factor, 20 ng / ml of epidermal growth factor, 50 ng / ml of adrenocorticotropic hormone, and 40 μg / ml of adenosine. Step 2: In vitro autologous hair follicle tissue In vitro autologous hair follicle tissue was immersed in culture solution A containing 2 U / ml neutral protease and incubated overnight. The next day, the hair follicle tissue was cut into pieces and digested with TrypLE at 37°C for 30 minutes, followed by vigorously pipetting. After pipetting, the suspension was filtered through a 100 μm sieve, the filtrate was centrifuged, phosphate buffer was added, and after washing three times, culture solution A was added to produce a hair follicle single cell suspension. The cell morphology of the mixed hair follicle cells in culture solution A is shown in Figure 1. Step 3: Expansion of mixed hair follicle cells The obtained single cell suspension of hair follicles was expanded in two stages using culture medium A and culture medium B. The mixed hair follicle cells were cultured at 5 × 10 4 The cells were inoculated at a cell concentration of 5 × 10 / ml onto a culture dish that had been covered with a substrate for 4 hours, culture medium A was added, and the cells were expanded under conditions of 5% CO2 and 37°C. The liquid was replaced every other day, and the cells were passaged when the confluence rate reached 80% or more. After passage, the cells were cultured at a cell concentration of 5 × 10 4 The cells were seeded at a cell concentration of / ml onto a culture dish covered with a substrate for 4 hours, and culture medium B was added and expanded under conditions of 5% CO2 and 37°C. The liquid was replaced every other day, and when the cell confluence rate reached 80%, the simultaneous expansion culture of hair follicle stem cells, pre-melanocytes, and keratinocytes was completed. The cell morphology of the hair follicle mixed cells in culture medium B is shown in Figure 2. Step 4: Hair follicle mixed cell differentiation and tissue formation After expansion, the mixed hair follicle cells were cultured at 1 × 10 4 pieces / cm 2 The cells were seeded at a density onto a substrate-coated culture dish and cultured in culture medium B under conditions of 5% CO2 and 37°C. When the confluence rate reached 80%, the culture medium was changed to culture medium C, and the liquid was exchanged every other day. Hair follicle mixed cells, which were rich in hair follicle stem cells, pre-melanocytes, and keratinocytes, were induced to differentiate into mature epidermal cells in culture medium C, and the matured cells were arranged in layers, and the epidermal cells were tightly bound together by the action of culture medium C, resulting in a tissue structure similar to physiological epidermis, completing the production. The cell morphology of the hair follicle mixed cells in culture medium C is shown in Figure 3. According to the manufacturing method of Example 1, it is possible to manufacture economical multi-layered tissue-engineered skin made of hair follicle cells, and under such manufacturing conditions, the most hair follicle-derived tissue-engineered epidermis was obtained. The morphological structure of melanocytes in the hair follicle mixed cells is shown in Figure 4. In Example 1, the multi-layered tissue-engineered skin made of hair follicle cells is shown in Figure 5.
[0028] Example 2 Step 1: Prepare the culture medium Preparation of coated substrate: When the volume is 500 ml, the components are 500 ml of commercially available phosphate buffer and 50 μg / ml of type IV collagen. Preparation of culture medium A: When the volume is 500 ml, the components are 500 ml of a commercially available keratinocyte medium with clearly defined components, 10 ng / ml of insulin-like growth factor, 3 ng / ml of keratinocyte growth factor, 200 ng / ml of endothelin, 50 ng / ml of melanocyte-stimulating hormone α, and 50 μg / ml of gentamicin. Preparation of culture medium B: When the volume is 500 ml, the components are 500 ml of a commercially available keratinocyte medium with clearly defined components, 10 ng / ml of insulin-like growth factor, 4 ng / ml of basic fibroblast growth factor, 20 ng / ml of epidermal growth factor, 50 ng / ml of adrenocorticotropic hormone, and 50 ng / ml of melanocyte-stimulating hormone α. Preparation of culture medium C: When the volume is 500 ml, the components are 370 ml of commercially available DMEM medium, 125 ml of commercially available F12 medium, 5 ml of non-essential amino acids, 10 ng / ml of insulin-like growth factor, 5 μg / ml of taurine, 1 μg / ml of 5-hydroxytryptamine hydrochloride, 20 μg / ml of insulin, 20 μg / ml of recombinant transferrin, 4 ng / ml of basic fibroblast growth factor, 5 nM of triiodothyronine, 1.5 μg / ml of hydrocortisone, 3 ng / ml of keratinocyte growth factor, 20 ng / ml of epidermal growth factor, 50 ng / ml of adrenocorticotropic hormone, and 40 μg / ml of adenosine. Step 2: In vitro autologous hair follicle tissue In vitro autologous hair follicle tissue was immersed in culture medium A containing 2 U / ml neutral protease and incubated overnight. The next day, the hair follicle tissue was chopped into pieces and digested with TrypLE at 37°C for 50 minutes (in two separate batches), followed by vigorously pipetting. After pipetting, the suspension was filtered through a 100 μm sieve, the filtrate was centrifuged, phosphate buffer was added, and the mixture was washed three times. Culture medium A was then added to produce a single hair follicle cell suspension. Step 3: Expansion of mixed hair follicle cells The obtained single cell suspension of hair follicles was expanded in two stages using culture medium A and culture medium B. The mixed hair follicle cells were cultured at 5 × 10 5 The cells were inoculated at a cell concentration of 5 × 10 / ml onto a culture dish that had been covered with a substrate for 4 hours, culture medium A was added, and the cells were expanded under conditions of 5% CO2 and 37°C. The liquid was replaced every other day, and the cells were passaged when the confluence rate reached 80% or more. After passage, the cells were cultured at a cell concentration of 5 × 10 5 The cells were seeded at a cell concentration of / ml onto a culture dish that had been covered with a substrate for 4 hours, culture medium B was added, and the cells were expanded under conditions of 5% CO2 and 37°C. The liquid was changed every other day, and when the cell confluence rate reached 80%, the simultaneous expansion culture of hair follicle stem cells, pre-melanocytes, and keratinocytes was completed. Step 4: Hair follicle mixed cell differentiation and tissue formation After expansion, the mixed hair follicle cells were cultured at 8 × 10 4 pieces / cm 2 The cells were seeded at a density onto a substrate-coated culture dish and cultured in culture medium B under conditions of 5% CO2 and 37°C. When the confluence rate reached 80%, the culture medium was changed to culture medium C, and the liquid was changed every other day. Hair follicle mixed cells, rich in hair follicle stem cells, pre-melanocytes, and keratinocytes, were induced to differentiate into mature epidermal cells in culture medium C, and the matured cells were arranged in layers, with the epidermal cells tightly bound together by the action of culture medium C, resulting in a tissue structure similar to physiological epidermis, completing the production. According to the manufacturing method of Example 2, multi-layered tissue-engineered skin composed of hair follicle cells can be efficiently manufactured, and under such manufacturing conditions, hair follicle-derived tissue-engineered epidermis can be obtained in only 28 days, which is less than the number of Example 1. The quality of hair follicle-derived tissue-engineered epidermis is the same in the two examples.
[0029] In the above two examples, the ex vivo autologous hair follicles refer to hair follicles isolated from the human body.
[0030] The method of obtaining extracorporeal autologous hair follicles may be a conventional technique, such as sucking out the hair follicles with a hair follicle remover. A specific method of obtaining the hair follicles may be the FUE (follicle unit extraction) method used in hair transplantation, and more specifically, see Follicular Unit Extraction: Minimally invasive surgery for hair transplantation. Dermatol Surg. 2002; 28: 720-7. The tip of the hair follicle extracting device is pierced into the scalp skin under an electric press, the hair follicles are sucked out, and the hair follicles are lightly extracted with sterile elbow tweezers, and the structure of the hair follicles is completely maintained throughout the entire process.
[0031] In the above two examples, the manufactured multi-layered tissue-engineered skin contains melanoblasts and stem keratinocytes similar to physiological conditions. The multi-layered tissue-engineered skin is a stratified structure tissue having physiological basal layer, spinous layer, and granular layer, and contains abundant melanoblasts in the basal layer. The tissue-engineered skin has tight junctions between cells and good toughness, and contains abundant basal layer-like cells that divide actively. In the use of the manufactured multi-layered tissue-engineered skin, the multi-layered tissue-engineered skin is used for the manufacture of biomedical materials. It is useful for the treatment of pigmentation defects and epidermal defect diseases. For example, when the manufactured multi-layered tissue-engineered skin is used for the treatment of vitiligo in the stable stage, it can promote repigmentation of vitiligo, and can achieve healing of vitiligo without immune rejection from autologous origin.
[0032] The above description of the embodiments is provided to facilitate understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative effort. Therefore, the present invention is not limited to the above embodiments, and all improvements and modifications made by those skilled in the art based on the disclosure of the present invention that do not depart from the scope of the present invention should be included in the patent scope of the present invention.
Claims
1. 1. A method for producing multi-layered tissue engineered skin comprised of hair follicle cells, comprising: The method includes the steps of digesting autologous hair follicles in vitro, expanding and culturing the mixed hair follicle cells, and maturing and differentiating the mixed hair follicle cells and forming a tissue structure, In the step of digesting the in vitro autologous hair follicles, The hair follicle tissue is digested by a two-step enzyme digestion method, and the hair follicle bulge region, which mainly contains hair follicle stem cells and melanocytes, the outer root sheath, which is rich in keratinocytes, and the hair follicle region, which is rich in dermal papilla cells, are effectively digested to obtain hair follicle mixed cells; In the step of expanding the hair follicle mixed cells, The hair follicle single cell suspension containing the mixed hair follicle cells is expanded in two stages using culture medium A and culture medium B to obtain the mixed hair follicle cells after the expansion culture. In the step of maturing and differentiating the hair follicle mixed cells and forming a tissue structure, The hair follicle mixed cells after expansion culture are cultured in culture medium B until the confluence rate reaches 80%, and then cultured in culture medium C. The culture medium is changed every day during culture in culture medium C, and the hair follicle mixed cells rich in hair follicle stem cells, pre-melanocytes, and keratinocytes are induced to differentiate into mature epidermal cells in culture medium C, and the matured cells are arranged in layers, and the epidermal cells are tightly bound to each other by the action of culture medium C, forming a multi-layered tissue engineered skin composed of hair follicle cells. The culture solution A is When the volume is 500 ml, the components are 500 ml of a commercially available keratinocyte medium with clearly defined components, 1 to 10 ng / ml of insulin-like growth factor, 0.5 to 5 ng / ml of keratinocyte growth factor, 100 to 500 ng / ml of endothelin, 20 to 80 ng / ml of melanocyte-stimulating hormone α, and 20 to 100 μg / ml of gentamicin. The culture medium B is When the volume is 500 ml, the components are 500 ml of a commercially available keratinocyte medium with clearly defined components, 1-10 ng / ml of insulin-like growth factor, 1-10 ng / ml of basic fibroblast growth factor, 10-50 ng / ml of epidermal growth factor, 10-50 ng / ml of adrenocorticotropic hormone, and 20-80 ng / ml of melanocyte-stimulating hormone α, The culture solution C is The method for producing a culture medium comprising, when the volume is 500 ml, the components are 370 ml of commercially available DMEM medium, 125 ml of commercially available F12 medium, 5 ml of non-essential amino acids, 1-10 ng / ml of insulin-like growth factor, 1-10 μg / ml of taurine, 1-5 μg / ml of 5-hydroxytryptamine hydrochloride, 20-80 μg / ml of insulin, 10-50 μg / ml of recombinant transferrin, 1-10 ng / ml of basic fibroblast growth factor, 1-10 nM of triiodothyronine, 0.5-5 μg / ml of hydrocortisone, 0.5-5 ng / ml of keratinocyte growth factor, 10-50 ng / ml of epidermal cell growth factor, 10-50 ng / ml of adrenocorticotropic hormone, and 10-50 μg / ml of adenosine.
2. The method for digesting hair follicle tissue using a two-step enzymatic digestion method is as follows: A first enzymatic digestion step and a second enzymatic digestion step, In the first enzymatic digestion step, the in vitro autologous hair follicle tissue is immersed in culture solution A containing 0.6 to 2.4 U / ml neutral protease and incubated; The method for producing multi-layered tissue engineered skin consisting of hair follicle cells according to claim 1, characterized in that in the second enzymatic digestion step, the hair follicle tissue is cut into pieces, TrypLE is added and digested for 10 to 40 minutes, followed by vigorous pipetting, and after pipetting, the suspension containing the cells and tissue is filtered through a sieve, the filtrate is centrifuged, a phosphate buffer is added to the cell mass, and after washing 3 to 5 times, culture solution A is added to produce a hair follicle single cell suspension containing mixed hair follicle cells.
3. In the method of expanding a single hair follicle cell suspension containing mixed hair follicle cells in two stages using culture medium A and culture medium B, Mixed hair follicle cells were 4 ~10 6 The cells were inoculated at a cell concentration of 1 / ml onto a substrate-coated culture dish, culture medium A was added, and the mixture was incubated at 5% CO 2 The cells were expanded at 37° C., the liquid was replaced every other day, and when the confluence rate reached 80% or more, the cells were passaged. After passage, the cells were 4 ~10 6 The cells were inoculated at a cell concentration of 1 / ml onto a substrate-coated culture dish, culture medium B was added, and the mixture was incubated at 5% CO 2 The method for producing multilayered tissue engineered skin consisting of hair follicle cells according to claim 1, characterized in that the cells are expanded at 37°C, the liquid is replaced every other day, and when the simultaneous expansion culture of hair follicle stem cells, pre-melanocytes, and keratinocytes is completed, mixed hair follicle cells after expansion are obtained.
4. The method for producing a multi-layered tissue engineered skin composed of hair follicle cells according to claim 3, characterized in that the substrate for covering the culture dish is composed of, as components, 500 ml of commercially available phosphate buffer and 10 to 100 μg / ml of type IV collagen when the volume is 500 ml.
5. In the maturation and differentiation of hair follicle mixed cells and the formation of tissue structures, the hair follicle mixed cells after expansion culture were cultured for 10 4 ~10 5 pieces / cm 2 The plates were inoculated with medium B at 100 rpm for 24 hours at 5% CO. 2 The method for producing multi-layered tissue engineered skin consisting of hair follicle cells according to claim 1, characterized in that the cells are cultured at 37°C, and when the confluence rate reaches 80%, the culture medium is changed to culture medium C, and the liquid is replaced every other day.
6. A multi-layered tissue engineered skin produced by the method according to any one of claims 1 to 5, A multi-layered tissue engineered skin characterized by a stratified tissue structure having a physiological basal layer, a spinous layer, and a granular layer, and containing an abundance of melanoblasts in the basal layer.
7. 7. Use of the multi-layered tissue engineered skin according to claim 6, The multi-layered tissue engineered skin is used for the production of biomedical materials.
Citation Information
Patent Citations
Composition and methods for producing reconstituted skin
JP2015097524A
Artificial three-dimensional skin tissue, its array, and its manufacturing method
JP2017537654A
Method for amplification of hair follicle cell
JP2022035392A
